Tag: GW Pharmaceuticals
May 16, 2019
Marijuana Stocks by Industry
Investors have seen a rush in cannabis investment lead to a division of marijuana stocks by industry. Here's what the...
May 15, 2019
The Future of Medical Cannabis: Cannabinoid-based Pharmaceuticals
One of the most promising cannabis markets of the future can be found in the healthcare industry as pharmaceutical companies...
January 22, 2019
FSD Pharma Strengthens Drug Development with GW Executive
Rupert Haynes and Raza Bokhari of FSD Pharma discuss the company’s pharma initiative, synthetic cannabinoids and extraction methods.
November 26, 2018
FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer
FSD Pharma Inc, (CSE:HUGE) announced today the appointment of Rupert Haynes as Chief Executive Officer. Mr. Haynes is a highly...
November 9, 2018
Cannabis Weekly Round-Up: Jeff Sessions Steps Down
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... October 5, 2018
GW Pharmaceuticals Announces the Closing of Public Offering of ADSs
GW Pharmaceuticals (Nasdaq:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform,... September 27, 2018